Utility Therapeutics Ltd has received FDA approval for Pivya (pivmecillinam) tablets to treat female adults with uncomplicated urinary tract infections (UTIs) caused by susceptible strains of Escherichia coli, Proteus mirabilis, and...
ImmunityBio, Inc, a biotechnology firm, declared that Anktiva (N-803, or nogapendekin alfa inbakicept-pmln) plus Bacillus Calmette-Guérin (BCG) is now approved by the US Food and Drug Administration for the treatment of patients with BCG...
PRISM BioLab, a biotechnology firm, is proposing little particle inhibitors of protein-protein interaction (PPI) targets, declared that it has gone into an objective selective exploration and licensing agreement with ONO PHARMACEUTICAL CO...
Sightsavers India, a development organisation dedicated to eliminating avoidable blindness and promoting equality of opportunity for individuals with disabilities, announces the commencement of applications for its annual Fellowship Programme
The nation's drug and pharmaceutical exports rose 9.67 percent year-on-year to USD 27.9 billion in 2023-24, even though total exports decreased by 3% in the previous fiscal year. Pharma exports increased by 12.73 percent to USD 2.8 billion in...
The recent Mumbai edition of analytica Anacon India and India Lab Expo, organised jointly by Messe Muenchen India and the Indian Analytical Instruments Association (IAIA), concluded successfully with satisfied exhibitors and delighted visitors.
Lupin Limited, a leading global pharmaceutical company, has secured the Establishment Inspection Report (EIR) from the US Food and Administration (FDA) for its Aurangabad manufacturing facility. The investigation was led from March 6 to March 15...
Sarvodaya Hospital, a leading multidisciplinary tertiary care facility in Greater Noida West, witnessed a groundbreaking advancement in orthopedic surgery as a 70-year-old male underwent a transformative Total Knee Replacement (TKR)
Pfizer Inc., a biopharmaceutical firm, reported that Emblaveo (aztreonam-avibactam) has received marketing approval from the European Commission (EC) for the treatment of adult patients with pyelonephritis, hospital-acquired pneumonia (HAP)...
Ipsen, a worldwide biopharmaceutical organization, announced a worldwide collaboration with Skyhawk Therapeutics, a clinical-stage biopharmaceutical organization, to find and foster novel little particles that tweak RNA for intriguing neurological...